The ‘race realist’ on campus
By Jason Fagone,
San Francisco Chronicle
| 06. 24. 2021
Why was Professor Gregory Christainsen allowed to teach Black and Latino students at Cal State East Bay that they were inherently less smart?
With one painful exception that she still thinks about today, Marisol Schowengerdt enjoyed her classes at Cal State East Bay.
She enrolled in 2014 at age 41, older than most students, but no one gave her a hard time. The university’s Hayward campus was an inviting, diverse place, as East Bay’s marketing stresses: 86% of undergraduates are non-white, and many are the first in their families to attend college. Even at the business school, where a stock ticker flashed market prices as students arrived to class, officials emphasized social justice.
“The ‘American Dream’ is the ideal that everyone living in the U.S. should have an equal opportunity to achieve success and prosperity,” reads a recent mission statement by East Bay’s College of Business and Economics. “We make the Dream possible for an exceptionally diverse student population.”
Schowengerdt is the daughter of an immigrant cherry farmer, a man born in Mexico who came to the U.S. in the mid-’60s and raised seven children. She had spent her 20s and 30s building a successful career in California real estate and finance. But she lacked a...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...